Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. All of these stories have one thing in common: They were all caused by ...
* SAYS PRELIM 2019 NET PROFIT AT 620.4 MILLION YUAN ($88.47 million) VERSUS NET LOSS OF 1.5 BILLION YUAN YEAR EARLIER Source text in Chinese: bit.ly/2uvY8Z7 Further company coverage: ($1 = 7.0128 ...
A sick child taking medication Real-world data on use of RAAS inhibitors can be used to support future pragmatic studies to optimize management of childhood-onset SLE, according to investigators.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results